Clinical activity of LOXO-292, a highly selective RET inhibitor, in patients with RET fusion+ non-small cell lung cancer Meeting Abstract
| Authors: | Oxnard, G.; Subbiah, V.; Park, K.; Bauer, T.; Wirth, L.; Velcheti, V.; Shah, M.; Besse, B.; Boni, V.; Reckamp, K.; Loong, H.; Bazhenova, L.; Solomon, B.; Tan, D.; Patel, J.; Johnson, M.; Gazzah, A.; Mok, T.; Smith, S.; Tuch, B.; Ebata, K.; Zhu, E.; Nguyen, M.; Huang, X.; Cruickshank, S.; Rothenberg, S.; Drilon, A. |
| Abstract Title: | Clinical activity of LOXO-292, a highly selective RET inhibitor, in patients with RET fusion+ non-small cell lung cancer |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | fusion; ret; loxo-292 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S349 |
| End Page: | S350 |
| Language: | English |
| ACCESSION: | WOS:000454014500287 |
| DOI: | 10.1016/j.jtho.2018.08.304 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OA12.07 -- Source: Wos |
